About the Company
Myovant Sciences aspires to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. Myovant Sciences has one FDA-approved medicine, ORGOVYX™ (relugolix), for adult patients with advanced prostate cancer. Its lead product candidate, relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg), is under regulatory review in Europe and the U.S. for women with uterine fibroids and is under development for women with endometriosis. Myovant Sciences is also developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, which has completed a Phase 2a study for female infertility as part of assisted reproduction. Sumitovant Biopharma, Ltd., a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., is its majority shareholder.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $MYOV News
Roivant Sciences Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
MILLENNIUM PHARMACEUTICALS INC's Net Worth
Inc., and Myovant Sciences Ltd.. Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive ...
Daniel S. Sundheim's Net Worth
Who is Daniel S. Sundheim? Daniel S. Sundheim has an estimated net worth of $1.26 Billion. This is based on reported shares across multiple companies, which include Maplebear Inc., Editas Medicine ...
Roivant Sciences Ltd (ROIV) Stock: Understanding the Volatility
Roivant Sciences Ltd (NASDAQ: ROIV) has a higher price-to-earnings ratio of 2.10x compared to its average ratio, The 36-month beta value for ROIV is at 1.33. Analysts have varying views on the stock, ...
WAVE Life Sciences Ltd WVE
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
BioLight Life Sciences Ltd BOLT
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
JFL Life Sciences Ltd (JFLLIFE) Share Price
JFL Life Sciences Ltd share price was down by -1.63% from the previous closing price of ₹40.00. Who are peers of JFL Life Sciences Ltd? The peers of JFL Life Sciences Ltd are Sun Pharmaceuticals ...
Camlin Fine Sciences Ltd.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Tiziana Life Sciences Ltd (TLSA)
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company’s lead product candidate in ...
Roivant Sciences Ltd.
1 Day ROIV -2.06% DJIA -1.24% S&P 500 -1.46% Health Care/Life Sciences -1.02% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
Wave Life Sciences Ltd. (WVE)
CAMBRIDGE, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to ...
Loading the latest forecasts...